Aarti Pharmalabs Limited (BOM:543748)
India flag India · Delayed Price · Currency is INR
745.85
+8.90 (1.21%)
At close: May 8, 2025

Aarti Pharmalabs Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
May '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
Market Capitalization
72,18467,90239,41824,999--
Upgrade
Market Cap Growth
72.26%72.26%57.68%---
Upgrade
Enterprise Value
75,75370,77140,89226,947--
Upgrade
Last Close Price
796.50748.55432.81272.22--
Upgrade
PE Ratio
26.5024.9318.1712.92--
Upgrade
PS Ratio
3.403.202.131.29--
Upgrade
PB Ratio
3.633.412.241.60--
Upgrade
P/TBV Ratio
3.823.592.351.65--
Upgrade
P/FCF Ratio
--64.8916.89--
Upgrade
P/OCF Ratio
21.7720.4818.229.99--
Upgrade
EV/Sales Ratio
3.563.332.211.39--
Upgrade
EV/EBITDA Ratio
15.9714.9210.597.88--
Upgrade
EV/EBIT Ratio
19.5418.2613.079.64--
Upgrade
EV/FCF Ratio
-107.49-67.3118.21--
Upgrade
Debt / Equity Ratio
0.210.210.160.140.250.08
Upgrade
Debt / EBITDA Ratio
0.870.870.740.631.65-
Upgrade
Debt / FCF Ratio
--4.701.46--
Upgrade
Asset Turnover
0.770.770.770.911.18-
Upgrade
Inventory Turnover
1.831.831.702.24--
Upgrade
Quick Ratio
1.111.110.900.860.8011.42
Upgrade
Current Ratio
2.012.011.941.941.7711.42
Upgrade
Return on Equity (ROE)
14.54%14.54%13.08%13.14%17.63%-2.00%
Upgrade
Return on Assets (ROA)
8.83%8.83%8.10%8.16%10.10%-1.15%
Upgrade
Return on Capital (ROIC)
10.90%10.90%10.25%9.98%11.92%-1.16%
Upgrade
Return on Capital Employed (ROCE)
17.20%17.20%16.60%17.00%11.30%-
Upgrade
Earnings Yield
3.77%4.01%5.50%7.74%--
Upgrade
FCF Yield
-0.98%-1.04%1.54%5.92%--
Upgrade
Dividend Yield
0.47%-0.69%0.73%--
Upgrade
Payout Ratio
11.64%11.64%8.36%9.37%--
Upgrade
Buyback Yield / Dilution
-0.05%-0.05%-0.01%--36150.40%-
Upgrade
Total Shareholder Return
0.42%-0.05%0.69%0.73%-36150.40%-
Upgrade
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.